MRI Can Detect Early Stages of Alzheimer’s Disease

Neuroscience Explains Risk-Taking Behavior With Bipolar Disorder
Neuroscience Explains Risk-Taking Behavior With Bipolar Disorder
Newly developed magnetic resonance imaging device coupled with an antibody can identify early beta-amyloid toxins in the brain.

Alzheimer’s disease can be identified much before you see the usual symptoms, says a Northwestern University team of scientists and engineers. The team has invented a noninvasive magnetic resonance imaging device, which coupled a magnetic nanostructure with an “antibody that seeks out the amyloid beta brain toxins,” going on to the beginning of Alzheimer’s disease.

The MRI scans of the brain can detect the toxins that have gathered as dark areas, due to the associated magnetic nanostructures. A new brain imaging method to identify the toxin leading to Alzheimer’s disease is available now, according to neuroscientist William L. Klein, leader of the research team, along with materials scientist Vinayak P. Dravid.

READ FULL ARTICLE Curated publisher From